Combined marine and plant extract compositions
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-035/32
A61K-035/34
A61K-036/81
A61K-036/185
A61K-036/87
A61K-031/715
출원번호
US-0853635
(2001-05-14)
등록번호
US-7435432
(2008-10-14)
우선권정보
DK-2000 00782(2000-05-12)
발명자
/ 주소
Olson,Bengt Krister
출원인 / 주소
Olson,Bengt Krister
대리인 / 주소
Roberts, Mlotkowski, Safran & Cole, P.C.
인용정보
피인용 횟수 :
4인용 특허 :
4
초록▼
A composition comprising cartilage extract, grape seed extract and tomato extract was found to have remarkable anti-oxidant effect and free-radical inhibition. The tomato extract comprises lycopene. The composition which comprises a hydrophilic antioxidant, a lipophilic (hydrophobic) antioxidant, a
A composition comprising cartilage extract, grape seed extract and tomato extract was found to have remarkable anti-oxidant effect and free-radical inhibition. The tomato extract comprises lycopene. The composition which comprises a hydrophilic antioxidant, a lipophilic (hydrophobic) antioxidant, and a cartilage extract dramatically increases collagen synthesis in the dermis. Furthermore, the composition lowers collagenase activity and levels of advanced glycation end products (AGE). The signs of ageing, such as photoageing due to exposure to UV radiation, are related to the levels of collagen syntheses and free-radical oxidation. Compositions of the invention are intended for the treatment of ageing skin and the delaying of the onset of the signs of ageing in healthy skin.
대표청구항▼
The invention claimed is: 1. A method of increasing collagen synthesis or lessening the decrease in collagen synthesis in the dermis comprising the oral administration to a human in need thereof of a composition comprising: i) at least one glycosaminoglycan found in cartilage enzymatic hydrolysate,
The invention claimed is: 1. A method of increasing collagen synthesis or lessening the decrease in collagen synthesis in the dermis comprising the oral administration to a human in need thereof of a composition comprising: i) at least one glycosaminoglycan found in cartilage enzymatic hydrolysate, or a synthetic form of at least one glycosaminoglycan; ii) at least one polyphenolic, hydrophilic antioxidant found in grape seed; or synthetic form of at least one polyphenolic hydrophilic antioxidant and esters thereof; and iii) lycopene; and wherein the weight ratio of the at least one polyphenolic, hydrophilic antioxidant to the 1 lycopene is about 1:1 to about 200:1 and the weight ratio of the at least one glycosaminoglycan to the at least one polyphenolic, hydrophilic antioxidant is about 1:1 to about 200:1. 2. A method according to claim 1, wherein the at least one polyphenolic, hydrophilic antioxidant is obtained from a grape seed extract. 3. A method according to claim 2, wherein the grape seed extract is obtained by using organic solvents. 4. A method according to claim 3, wherein said grape seed extract comprises up to 25% w/w of catechin, epicatechin or gallic acid; up to 90% w/w of epicatechin dimer, trimer or tetramer, or gallates thereof, or up to 10% w/w of epicatechin pentamer, hexamer or heptamer, or gallates thereof. 5. A method according to claim 3, wherein the grape seed extract is obtained by using the organic solvents, evaporating the solvents, re-dissolving a residue in water, and filtering and drying a filtrate. 6. A method according to claim 3, wherein the organic solvents are selected from the group consisting of acetone, ethyl acetate and mixtures thereof. 7. A method according to claim 1, wherein said at least one polyphenolic, hydrophilic antioxidant is obtained from at least one natural source. 8. A method according to claim 1, wherein said at least one polyphenolic, hydrophilic antioxidant comprises an oligomeric procyanidol. 9. A method according to claim 1, wherein said lycopene is obtained from a tomato variety. 10. A method according to claim 1, wherein said lycopene is obtained from a tomato extract. 11. A method according to claim 1, wherein said composition, further comprises a carotenoid comprising β-carotene, γ-carotene, δ-carotene, zeaxanthin, cryptoxanthine, lutein, xanthophyll, or a combination thereof. 12. A method according to claim 11, wherein the composition comprises less than 0.025% β-carotene by weight. 13. A method according to claim 1, wherein the composition comprises said lycopene in an amount of 0.1 to 5% wt/wt. 14. A method according to claim 1, wherein the composition comprises 0.25-15 mg of the lycopene and further comprises 2.5-100 mg of a grape seed extract. 15. A method according to claim 14, wherein said composition comprises 0.75-2.5 mg of the lycopene and 10-30 mg of the grape seed extract. 16. A method according to claim 1 wherein said composition comprises 1-2.5 mg of the lycopene, and further comprises 5-50 mg of a grape seed extract and 50-200 mg of a cartilage enzymatic hydrolysate. 17. A method according to 1, wherein said composition further comprises Acerola extract. 18. A method according to claim 1, wherein said composition is in a form for oral administration comprising tablets, powders, granules, capsules, sachets, solutions, suspensions, tonics of syrups, or a combination thereof. 19. A method according to claim 1, wherein said glycosaminoglycan is from a cartilage enzymatic hydrolysate obtained by enzymatic proteolytic cleavage of a cartilage. 20. A method according to claim 19, wherein said cartilage is selected from the group consisting of bovine cartilage, porcine cartilage, shark cartilage, squid cartilage, chicken cartilage and salmon cartilage. 21. A method according to claim 19, wherein the composition further comprises a cartilage enzymatic hydrolysate and a grape seed extract, and the cartilage enzymatic hydrolysate and the grape seed extract are present in a weight/weight ratio in the range of from about 5:1 to 15:1. 22. A method according to claim 21, wherein said composition comprises 1-2.5 mg of the lycopene, 5-50 mg of the grape seed extract and 50-200 mg of the cartilage enzymatic hydrolysate. 23. A method according to claim 19, wherein the composition further comprises a cartilage enzymatic hydrolysate and a grape seed extract, and the cartilage enzymatic hydrolysate and the grape seed extract are present in a weight/weight ratio of about 1:2 to 2:1. 24. A method according to claim 1, wherein said glycosaminoglycan is from a shark cartilage enzymatic hydrolysate obtained by enzymatic proteolytic cleavage of said shark cartilage. 25. A method according to any one of claims 1 and 19, wherein said glycosaminoglycan comprises chondroitin ester, a keratan ester, hyaluronic acid or an ester thereof, a dermatan ester, heparin or a heparan ester. 26. A method according to claim 25, wherein said composition comprises 1-2.5 mg of the lycopene, and further comprises 5-50 mg of a grape seed extract and 50-200 mg of a cartilage enzymatic hydrolysate. 27. A method according to any one of claims 1 and 19, wherein the composition further comprises a cartilage enzymatic hydrolysate, and the cartilage enzymatic h,/drolysate and the lycopene are present in a weight/weight ratio of about 1:2 to 2:1. 28. A method according to claim 1, wherein the weight ratio of the at least one polyphenolic, hydrophilic antioxidant to lycopene is 2:1 to 100:1. 29. A method according to claim 1, wherein the weight ratio of the at least one glycosaminoglycan to the at least one polyphenolic, hydrophilic antioxidant is 2:1 to 100:1. 30. A method according to claim 1, which includes a treatment of skin against the signs of skin ageing, and damage resulting from exposure to UV radiation. 31. A method according to claim 1, wherein the weight ratio of the at least one polyphenolic, hydrophilic antioxidant to lycopene is 5:1 to 50:1. 32. A method according to claim 1, wherein the weight ratio of the at least one polyphenolic, hydrophilic antioxidant to lycopene is 5:1 to 20:1. 33. A method according to claim 1, wherein the weight ratio of the at least one polyphenolic, hydrophilic antioxidant to lycopene is 5:1 to 15:1. 34. A method according to claim 1, wherein the weight ratio of the at least one polyphenolic, hydrophilic antioxidant to lycopene is 7:1 to 12:1. 35. A method according to claim 1, wherein the weight ratio of the at least one polyphenolic, hydrophilic antioxidant to lycopene is about 10:1. 36. A method according to claim 1, wherein the weight ratio of the at least one glycosaminoglycan to the at least one polyphenolic, hydrophilic antioxidant is 5:1 to 50:1. 37. A method according to claim 1, wherein the weight ratio of the at least one glycosaminoglycan to the at least one polyphenolic, hydrophilic antioxidant is 5:1 to 20:1. 38. A method according to claim 1, wherein the weight ratio of the at least one glycosaminoglycan to the at least one polyphenolic, hydrophilic antioxidant is 5:1 to 15:1. 39. A method according to claim 1, wherein the weight ratio of the at least one glycosaminoglycan to the at least one polyphenolic, hydrophilic antioxidant is 7:1 to 12:1. 40. A method according to claim 1, wherein the weight ratio of the at least one glycosaminoglycan to the at least one polyphenolic, hydrophilic antioxidant is about 10:1.
Cohen, Miguel Angel Alonso; Di Schiena, Michele Giuseppe; Di Fulvio, Marco, Composition based on xyloglucan and proteins for the treatment of intestinal disorders.
Story, Brooks J.; Wadsworth, Scott A.; Parrish, William R.; Herzberg, Uri; Torres, Donna; Byers, Benjamin A.; Hwang, Julia; Su, Dongling, Compositions and methods for treating joints.
Byers, Benjamin A.; Su, Dongling; Hwang, Julia, Methods for forming compositions for treating joints comprising bone morphogenetic protein and hyaluronic acid.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.